NASDAQ Composite opens in less than hour and Castle Biosciences‘s pre-market value is already 5.07% down.
The last session, NASDAQ Composite finished with Castle Biosciences dropping 9.18% to $54.78. NASDAQ Composite fell 2.55% to $13,401.86, following the last session’s downward trend on what was an all-around negative trend trading session.
Castle Biosciences’s last close was $60.32, 96.59% under its 52-week high of $107.69.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth declined by 1.9%, now sitting on 62.65M for the twelve trailing months.
Castle Biosciences’s last day, last week, and last month’s current volatility was 7.25%, 5.69%, and 3.37%, respectively.
Castle Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.81% (day), 7.33% (last week), and 5.97% (last month), respectively.
More news about Castle Biosciences.